Biotecnología
Biotecnología
California Biomanufacturing Center Launches the BioP2P Network
14/10/2022 -
Aims to accelerate the transformation of manufacturing in the United States for the growing bioeconomy.
Pharmacogenetic testing shows promise improving symptoms in patients with treatment-resistant depression
26/04/2022 -
Pharmacogenetic testing was associated with nearly a two-fold (89 per cent) increase in remission rates compared to treatment as usual in a recent clinical study.
Largest genetic study of migraine to date reveals new genetic risk factors
26/04/2022 -
Scientists identified more than 120 regions of the genome that are connected to risk of migraine. The groundbreaking study helps researchers better understand the biological basis of migraine and its...
Researchers develop a new class of CAR-T cells that target previously untargetable cancer drivers
26/04/2022 -
In a breakthrough for the treatment of aggressive solid cancers, researchers have developed a novel cancer therapy that targets proteins inside cancer cells that are essential for tumor growth and...
Personalized immunotherapy: Rapid screening of therapeutic combinations
26/04/2022 -
An innovative testing platform that more closely mimics what cancer encounters in the body may allow for more precise, personalized therapies by enabling the rapid study of multiple therapeutic...
Genetic risk for asthma comes from changes in airway cells, study finds
26/04/2022 -
A significant amount of genetic risk for asthma is likely mediated through altered gene expression within the airway epithelium. That is the conclusion of a new study to identify genetic variants...
Scientists identify germline signature that predicts side effects from anti-PD1/PDL1 checkpoint therapy
26/04/2022 -
Investigators have identified a germline biomarker signature that successfully predicts which patients will suffer serious side effects that occur in up to 3 in ten patients on anti-PD1/PDL1 therapy,...
New test to diagnose aggressive childhood brain tumors
26/04/2022 -
Researchers have developed a new test to more easily diagnose medulloblastoma, the most common malignant childhood brain tumor. The test -- which can distinguish between extremely high-risk...
MET amplification as driver for some non-small cell lung cancers
26/04/2022 -
A study has helped define MET amplification as an actionable driver for some non-small cell lung cancers.
Chronologically young, biologically old: DNA linked to cancer survivors premature aging
26/04/2022 -
Scientists have identified variants in two genes that are associated with accelerated aging in childhood cancer survivors.
How the timing of dinner and genetics affect individuals’ blood sugar control
26/04/2022 -
Eating dinner close to bedtime, when melatonin levels are high, disturbs blood sugar control, especially in individuals with a genetic variant in the melatonin receptor MTNR1B, which has been linked...
Gene signature identifies drivers of treatment resistance in metastatic breast cancer
26/04/2022 -
A multi-institution team of researchers has discovered a genetic signature that can identify drivers of poor outcomes in advanced estrogen-receptor positive (ER+) breast cancer, which could one day...
Innovative gene therapy 'reprograms' cells to reverse neurological deficiencies
26/04/2022 -
A novel method of gene therapy is helping children born with a rare genetic disorder called AADC deficiency that causes severe physical and developmental disabilities. The study offers new hope to...
NIH's All of Us Research Program releases first genomic dataset of nearly 100,000 whole genome sequences
26/04/2022 -
Nearly 100,000 highly diverse whole genome sequences are now available through the National Institutes of Health's All of Us Research Program. About 50 percent of the data is from individuals...
Most 'pathogenic' genetic variants have a low risk of causing disease
26/04/2022 -
Researchers discovered that the chance a pathogenic genetic variant may actually cause a disease is relatively low - about 7 percent. They also found that some variants, such as those associated with...
Most commonly mutated gene in all cancers revealed
26/04/2022 -
For the past fifteen years, cancer researchers have been using DNA sequencing technology to identify the gene mutations that cause the different forms of cancer. Now, computational scientists have...
Personalized medicine for cats with heart disease
26/04/2022 -
Veterinarians at the University of California, Davis, have found that a cat's DNA alters how it responds to a life-saving medication used to treat hypertrophic cardiomyopathy, or HCM, a heart...
Genomic profiling of pediatric cancer may expand treatment options for patients experiencing a relapse
26/04/2022 -
Genomic sequencing of tumors from pediatric cancer patients experiencing a relapse enabled 107 patients to receive an appropriate matched therapy that is not the standard of care, according to new...
New AI model helps discover causes of motor neurone disease
26/04/2022 -
Scientists have developed a new machine learning model for the discovery of genetic risk factors for diseases such as Motor Neurone Disease (MND).
‘Research autopsy’ enable scientists study why certain cancer therapies stop working
26/04/2022 -
A new research study turns cancer scientists into molecular detectives, searching for clues for why certain cancers are able to spread and evolve by studying tissues collected within hours of death.
Gene profile in blood predicts risk of poor outcomes, death for patients with COVID-19
26/04/2022 -
A previously validated blood gene profile that predicts idiopathic pulmonary fibrosis mortality was repurposed to assess the likelihood of COVID-19 survival, a new study reports,
